Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Abusing steroids can damage your heart, muscles, reproductive system, liver, skin, and brain, and may increase the risk of Alzheimer's disease.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

The higher dose supplement was more effective in treating female hair loss.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Combining oral minoxidil and bicalutamide may help improve hair growth in adolescent girls.

Using 5α-reductase inhibitors for hair loss may increase the risk of dry eye disease.

Flutamide treatment showed no significant changes in mice vaginal mucosa.

New treatments for male hair loss are being explored to improve effectiveness and reduce side effects.

Finasteride 5 mg/day effectively treats hair loss in postmenopausal women without hyper-androgenism.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Stopping the drug usually helps, but tamoxifen or surgery may be needed if symptoms persist.

Minoxidil might partially activate estrogen receptors, affecting hair growth.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Bicalutamide may improve hair growth in postmenopausal women with mild side effects.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Nuclear AR levels give better insight into hormone effects in skin conditions.

We need better ways to test and understand SARMs to make safer and more effective treatments.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

Finasteride and dutasteride both improve hair growth effectively, but dutasteride has stronger anti-androgen effects and finasteride may cause more sexual side effects.

Cyproterone acetate combined with ethinyl estradiol significantly reduced hirsutism in women.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Azathioprine can rarely cause hair loss, which improves after stopping the drug.

Minoxidil not effective in preventing chemotherapy-induced hair loss.